Evidence map›Paper›PMID 26177095›Full record

ArticlePloS one2015

An Enzymatically Active β-1,3-Glucanase from Ash Pollen with Allergenic Properties: A Particular Member in the Oleaceae Family.

María Torres, Oscar Palomares, Joaquín Quiralte, Gabrielle Pauli, Rosalía Rodríguez, Mayte Villalba

Abstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Perspectives of Proteomics in Respiratory Allergic Diseases.International journal of molecular sciences · 2023
    Review
  3. Article
  4. The World Allergy Organization journal · 2020
    Article
  5. Article
  6. Evidence-based complementary and alternative medicine : eCAM · 2017
    Review
  7. Pollen Allergens for Molecular Diagnosis.Current allergy and asthma reports · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

María TorresBiochemistry and Molecular Biology I Department Complutense, University of Madrid, Madrid, Spain.
Oscar PalomaresBiochemistry and Molecular Biology I Department Complutense, University of Madrid, Madrid, Spain.
Joaquín QuiralteVirgen del Rocío University, Hospital of Seville, Seville, Spain.
Gabrielle PauliHôpital Lyautey, Hopitaux Universitaires de Strasbourg, Strasbourg, France.
Rosalía RodríguezBiochemistry and Molecular Biology I Department Complutense, University of Madrid, Madrid, Spain.
Mayte VillalbaBiochemistry and Molecular Biology I Department Complutense, University of Madrid, Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Endo-β-1,3-glucanases are widespread enzymes with glycosyl hydrolitic activity involved in carbohydrate remodelling during the germination and pollen tube growth. Although members of this protein family with allergenic activity have been reported, their effective contribution to allergy is little known. In this work, we identified Fra e 9 as a novel allergenic β-1,3-glucanase from ash pollen. We produced the catalytic and carbohydrate-binding domains as two independent recombinant proteins and characterized them from structural, biochemical and immunological point of view in comparison to their counterparts from olive pollen. We showed that despite having significant differences in biochemical activity Fra e 9 and Ole e 9 display similar IgE-binding capacity, suggesting that β-1,3-glucanases represent an heterogeneous family that could display intrinsic allergenic capacity. Specific cDNA encoding Fra e 9 was cloned and sequenced. The full-length cDNA encoded a polypeptide chain of 461 amino acids containing a signal peptide of 29 residues, leading to a mature protein of 47760.2 Da and a pI of 8.66. An N-terminal catalytic domain and a C-terminal carbohydrate-binding module are the components of this enzyme. Despite the phylogenetic proximity to the olive pollen β-1,3-glucanase, Ole e 9, there is only a 39% identity between both sequences. The N- and C-terminal domains have been produced as independent recombinant proteins in Escherichia coli and Pichia pastoris, respectively. Although a low or null enzymatic activity has been associated to long β-1,3-glucanases, the recombinant N-terminal domain has 200-fold higher hydrolytic activity on laminarin than reported for Ole e 9. The C-terminal domain of Fra e 9, a cysteine-rich compact structure, is able to bind laminarin. Both molecules retain comparable IgE-binding capacity when assayed with allergic sera. In summary, the structural and functional comparison between these two closely phylogenetic related enzymes provides novel insights into the complexity of β-1,3-glucanases, representing a heterogeneous protein family with intrinsic allergenic capacity.

Indexed as

AllergensAmino Acid SequenceAntigens, Plantbeta-GlucosidaseCatalytic DomainCloning, MolecularEscherichia coliFraxinusGene ExpressionGlucan 1,3-beta-GlucosidaseHumansImmune SeraImmunoglobulin EMolecular Sequence DataOleaOpen Reading FramesAllergensAntigens, Plantbeta-GlucosidaseGlucan 1,3-beta-GlucosidaseImmune SeraImmunoglobulin EOLE9 protein, Olea europaeaPlant ProteinsProtein Sorting SignalsRecombinant Proteins

Identifiers

PMID26177095
PMCPMC4503641

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.